The influence of zoledronic acid on proliferation, migration and apoptosis of fibroblasts

doi:10.19439/j.sjos.2019.05.008

Abstract

Abstract: PURPOSE: Bisphosphonates are commonly used to treat bone-derived malignant tumors currently. In recent years, with the widespread use of these drugs, reports on the difficulty of wound healing (DWH) increase remarkably. However, the mechanism is still unclear. The soft tissue injury was suspected to cause DWH in many recent reports. This experiment was designed to explore the influence of zoledronic acid on fibroblast, and investigate the possible mechanisms leading to DWH. METHODS: NIH 3T3 fibroblasts were routinely cultured in vitro. The influence of zoledronic acid on apoptosis, proliferation and migration of fibroblast were tested with flow cytometry, MTT and cell migration assay, respectively. The results of each experimental group were compared with the control group using SPSS 17.0 software package. RESULTS: At a concentration of 5~50 μmol/L, zoledronic acid could dose-dependently inhibit the activity of fibroblast proliferation and migration, and up-regulate apoptosis with significant difference (P<0.05). CONCLUSIONS: Zoledronic acid can up-regulate cell apoptosis, inhibit proliferation and migration of fibroblast, suggesting that soft tissue impairment might contribute to the occurrence of DWH.

Key words: Zoledronic acid, Fibroblast, Apoptosis, Proliferation, Migration

CLC Number:

R739.8

LANG Miao-jie, OU Yue-jian. The influence of zoledronic acid on proliferation, migration and apoptosis of fibroblasts[J]. Shanghai Journal of Stomatology, 2019, 28(5): 490-493.

References

[1] 杨便红. 多发性骨髓瘤使用双瞵酸盐引起颌骨坏死的探讨与护理[J]. 中华现代护理杂志, 2009, 15(15): 1449-1450.
[2] 杨万群, 黄飚, 梁长虹. 双瞵酸盐相关性颌骨坏死影像学研究进展[J]. 中国医学影像技术, 2010, 26(2): 381-383.
[3] Honda Y, Takahashi S, Zhang Y, et al.Effects of bisphosphonate zoledronic acid in hepatocellular carcinoma, depending on mevalonate pathway[J]. J Gastroenterol Hepatol, 2015, 30(3): 619-627.
[4] Luckman SP, Hughes DE, Coxon FP, et al.Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras[J]. J Bone Miner Res, 1998, 13(4):581-589.
[5] Adepitan AO, Ariel B, Lauren L, et al.Osteonecrosis of the jaw in patients treated with denosumab for metastatic tumors to the bone: A series of thirteen patients[J]. J Craniomaxillofac Surg, 2016, 44(3): 265-270.
[6] Kuroshima S, Go VA, Yamashita J.Increased numbers of nonattached osteoclasts after long-term zoledronic acid therapy in mice[J]. Endocrinology, 2012, 153(1): 17-28.
[7] Brown JP, Morin S, Leslie W, et al.Bisphosphonates for treatment of osteoporosis: Expected benefits, potential harms, and drug holidays[J]. Can Fam Physician, 2014, 60(4): 324-333.
[8] Walter C, Pabst A, Ziebart T, et al.Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro[J]. Oral Dis, 2011, 17(2): 194-199.
[9] Vigorita VJ, Silver JS, Eisemon EO.Osteoclast abnormalities in fractured bone during bisphosphonate treatment for osteoporosis: a case report[J]. Skeletal Radiol, 2012, 41(7):861-865.
[10] 李公超. Ⅰ:帕米瞵酸钠对成骨不全成骨细胞和成纤维细胞增殖分化的研究Ⅱ成骨不全成纤维细胞永生化细胞系的建立[D]. 济南: 济南大学, 2011.
[11 Goodwin JS, Zhou J, Kuo YF, et al. Risk of jaw osteonecrosis after intravenous bisphosphonates in cancer patients and patients without cancer[J]. Mayo Clin Proc, 2017, 92(1): 106-113.
[12] Koth VS, Figueiredo MA, Salum FG, et al.Interrelationship of clinical, radiographic and haematological features in patients under bisphosphonate therapy[J]. Dentomaxillofac Radiol, 2017, 46(4): 20160260.
[13] Bagan JV, Jimenez Y, Murillo J, et al.Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions: study of 20 cases[J]. Oral Oncol, 2006, 42(3): 327-329.
[14] Hasegawa T, Kawakita A, Ueda N, et al.A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?[J]. Osteoporos Int, 2017, 28(8): 2465-2473.
[15] 韩秀丽, 庞雪晶, 兰柳萍, 等. 重组牛碱性成纤维细胞生长因子对腭裂整复术创口愈合的疗效观察[J]. 广东牙病防治, 2014, 22(10): 519-521.

[1]	LI Xin-ran, CHEN Lin, MENG Jian. Inhibitory effect and mechanism of sodium cantharidate on human tongue squamous cell carcinoma CAL27 cells [J]. Shanghai Journal of Stomatology, 2024, 33(3): 229-234.
[2]	ZHAO Jiong, BAI Guo, YANG Chi. Single-cell transcriptome characterization of oral mucosal fibroblasts [J]. Shanghai Journal of Stomatology, 2024, 33(1): 1-5.
[3]	SHEN Yi-fen, LIU Chao, TANG Ying, YANG Tao, GU Yong-chun. The role of ROS/JNK/caspase 3 axis in apoptosis induction by menthol-favored electronic cigarette liquid in human periodontal ligament stem cells [J]. Shanghai Journal of Stomatology, 2024, 33(1): 40-48.
[4]	LIU Wen-jing, LI Meng-qi, CUI Xiang, WANG Jun-lan. Study on the molecular mechanism of circ_0000326 regulating the proliferation, invasion and migration of oral squamous cell carcinoma HSC3 cells by targeting miR-567 [J]. Shanghai Journal of Stomatology, 2023, 32(6): 590-596.
[5]	LIU Yun, CHEN Hao-yue, MI Jing, WANG Fei-fei, WAN Guang-yong, CUI Chao. Inhibitory effect of paeoniflorin on CAL27 cells of tongue squamous cell carcinoma and its mechanism [J]. Shanghai Journal of Stomatology, 2023, 32(6): 597-602.
[6]	LI Sheng-nan, CUI Fei-yan, ZHAO Shan, DU Chen, MENG Jian. Corilagin-induced apoptosis of oral squamous carcinoma CAL-27 cells in vitro and in vivo and its mechanism [J]. Shanghai Journal of Stomatology, 2023, 32(5): 462-467.
[7]	LIU Yan, SHAN Dan-ni, SUN Jing, ZOU Yu-xi, YUAN Chang-yong. Effects of let-7a on proliferation, osteogenic differentiation and apoptosis of human dental pulp stem cells [J]. Shanghai Journal of Stomatology, 2023, 32(5): 468-474.
[8]	ZHOU Zi-chao, SHU Rong, WU Yi-qun. Effect of EPA on inflammatory response of human periodontal ligament fibroblasts induced by P. gingivalis LPS [J]. Shanghai Journal of Stomatology, 2023, 32(5): 475-479.
[9]	Dilidaer·Taxifulati, NIU Ya-qi, Reyisha·Abudukeyimu, WANG Lin. Effect of lncRNA AWPPH on human periodontal ligament cell proliferation and osteogenic differentiation by regulating Notch signaling pathway [J]. Shanghai Journal of Stomatology, 2023, 32(1): 23-27.
[10]	WEI Jun-shui, SUN Xin, XU Jin-biao, CHEN Yi-da. LncRNA RUNX1-IT1 regulating malignant pleomorphic adenoma via mir-195/CyclinD1 [J]. Shanghai Journal of Stomatology, 2023, 32(1): 85-90.
[11]	YANG En-li, WANG Na, LI Ming-yang, LI Yi-ming, GENG Yi-ming, ZHANG Dong-sheng, WU Hai-wei. Effect of shikonin on proliferation, apoptosis, migration and angiogenesis of hemangioma endothelial cell [J]. Shanghai Journal of Stomatology, 2022, 31(6): 576-580.
[12]	NA Fei, ZHOU Jian-zhong, HE Yong-wen, XIE Zhi-gang, WANG Quan, LI Zi-liang. Pilose antler polypeptide CNT14 promoted proliferation and migration of human oral mucosa fibroblast cells [J]. Shanghai Journal of Stomatology, 2022, 31(6): 607-614.
[13]	YUAN Wei-li, WANG Xu-kai. Effects of oral propranolol on urine bFGF, MMP-2, MMP-9 expression in children with proliferative infantile hemangioma [J]. Shanghai Journal of Stomatology, 2022, 31(4): 400-405.
[14]	QIN Zhi-ming, JIE Wei-ping, CHI Yan-ting, LI Hong-feng, LI Bin-bin. Preliminary establishment of an unsupervised quantification model of Ki-67 proliferation index based on local variable threshold method [J]. Shanghai Journal of Stomatology, 2022, 31(3): 248-254.
[15]	CHEN Qi, XIE Fei, JI Ying-ying, WEI Kui-jie, REN Qiang. LLY-283 inhibits proliferation and metastasis of head and neck squamous cell carcinoma by targeting PRMT5 [J]. Shanghai Journal of Stomatology, 2022, 31(2): 142-147.